Chemistry:Dinapsoline
From HandWiki
Short description: Chemical compound
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
Chemical and physical data | |
Formula | C16H15NO2 |
Molar mass | 253.301 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Dinapsoline is a drug developed for the treatment of Parkinson's disease,[1] that acts as a selective full agonist at the dopamine D1 receptor.[2][3][4][5]
References
- ↑ "Dinapsoline: characterization of a D1 dopamine receptor agonist in a rat model of Parkinson's disease". The Journal of Pharmacology and Experimental Therapeutics 296 (2): 338–44. February 2001. PMID 11160615.
- ↑ "9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore". Journal of Medicinal Chemistry 39 (2): 549–55. January 1996. doi:10.1021/jm950707+. PMID 8558526.
- ↑ "(+)-Dinapsoline: an efficient synthesis and pharmacological profile of a novel dopamine agonist". Journal of Medicinal Chemistry 45 (17): 3660–8. August 2002. doi:10.1021/jm0101545. PMID 12166939.
- ↑ "Synthesis and SAR exploration of dinapsoline analogues". Bioorg. Med. Chem. 12 (4): 715–34. February 2004. doi:10.1016/j.bmc.2003.11.015. PMID 14759732.
- ↑ "Effects of dopamine D1 receptor agonists in rats trained to discriminate dihydrexidine". Psychopharmacology 186 (1): 25–31. May 2006. doi:10.1007/s00213-006-0342-2. PMID 16575553.
0.00 (0 votes)
|